Preeclampsia and genetic risk factors for thrombosis: A case-control study

American Journal of Obstetrics and Gynecology

Volumn 181, Issue 4, 1999, Pages 975-980

  De Groot, Christianne J M ^a   Bloemenkamp, Kitty W M ^b   Duvekot, Ella J ^b   Helmerhorst, Frans M ^b   Bertina, Rogier M ^b   Van Der Meer, Felix ^b   De Ronde, Hans ^b   Oei, S Guid ^b   Kanhai, Humphrey H H ^b   Rosendaal, Frits R ^b  

^a MEDICAL CENTER HAAGLANDEN   (Netherlands)

^b NONE

Author keywords

Antithrombin deficiency; Factor V Leiden; Hereditary coagulation abnormalities; Preeclampsia; Prothrombin 20210A allele

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 5; PROTEIN C; PROTEIN S; PROTHROMBIN;

ADULT; ANTITHROMBIN DEFICIENCY; BLOOD CLOTTING DISORDER; CASE CONTROL STUDY; CONFERENCE PAPER; CONTROLLED STUDY; GENETIC DISORDER; HUMAN; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; PREECLAMPSIA; PRIORITY JOURNAL; RISK FACTOR; THROMBOSIS; VEIN THROMBOSIS;

EID: 0032740843     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(99)70335-2     Document Type: Conference Paper

References (25)

1. 1. Geary M. The HELPP syndrome. Br J Obstet Gynaecol 1997;104:887-91.
2. 2. Roberts JM, Redman CW. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 1993;341:1447-51.
3. 3. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989;161:1200-4.
4. 2. de Groot CJM, Taylor RN. Preeclampsia: an update. Eur J Obstet Gynecol Reprod Biol 1996;69:59-60.
5. 5. Dizon-Townson DS, Meline L, Nelson LM, Varner M, Ward K. Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction. Am J Obstet Gynecol 1997;177:402-5.
6. 6. Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999;340:9-13.
7. 7. Bertina R, Koeleman B, Koster T, Rosendaal F, Dirven R, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-7.
8. 8. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-703.
9. 9. National high blood pressure education program working group report on high blood pressure in pregnancy. Am J Obstet Gynecol 1990;163:1689-712.
10. 10. Kloosterman GJ. On intrauterine growth, the significance of prenatal care. Int J Gynaecol Obstet 1970;8:895-912.
11. 11. Dahlbäck B. Factor V gene mutation causing inherited resistance to activated protein C as a basis for venous thromboembolism. J Int Med 1995;237:221-7.
12. 12. de Ronde H, Bertina R. Laboratory diagnosis of APC-resistance: a critical evaluation of the test and the development of diagnostic criteria. Thromb Haemost 1994;72:880-6.
13. 13. Poort S, Bertina R, Vos H. Rapid detection of the Prothrombin 20210 A variation by allele specific PCR. Thromb Haemost 1997;78:1157-8.
14. 14. Boyer C, Rothchild C, Wolf M, Amiral J, Meyer D, Larrieu M. A new method for the estimation of protein C by ELISA. Thromb Res 1984;36:579-89.
15. 15. Deutz-Terlouw P, Ballering L, van Wijngaarden A, Bertina R. Two ELISA's for measurement of protein S and their use in the laboratory diagnosis or protein S deficiency. Clin Chim Acta 1989;186:321-34.
16. 16. Dizon-Townson DS, Nelson LM, Easton K, Ward K. The factor V Leiden mutation may predispose women to severe preeclampsia. Am J Obstet Gynecol 1996;175:902-5.
17. 17. Dekker GA, de Vries JI, Doelitzsch PM, Huijgens PC, von Blomberg BM, Jacobs C, et al. Underlying disorders with severe early-onset preeclamsia. Am J Obstet Gynecol 1995;173:1042-8.
18. 18. Bloemenkamp KWM, Rosendaal FR, Helmerhorst FM. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing third generation progestogen. Lancet 1995;346:566-8.
19. 19. Ridker PM, Miletich JP, Hennekens CH, Buring JE. Ethnic distribution of Factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. JAMA 1997;277:1305-7.
20. 20. Dizon-Townson DS, Nelson LM, Jang H, Varner MW, Ward K. The incidence of the factor V Leiden mutation in an obstetric population and its relationship to deep vein thrombosis. Am J Obstet Gynecol 1997;176:883-6.
21. 21. Pauer H-U, Neesen J, Hinney B. Factor V Leiden and its relevance in patients with recurrent abortions [letter]. Am J Obstet Gynecol 1998;178:629.
22. 22. Price DT, Ridker PM. Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective. Ann Intern Med 1997;127:895-903.
23. 23. McColl MD, Ramsay JE, Tait RC, Walker ID, McCall F, Conkie JA, et al. Risk factors for pregnancy associated venous thromboembolism. Thromb Haemost 1997;78:1183-8.
24. 24. Middeldorp S, Henkens CMA, Koopman MMW, van Pampus ECM, Hamulyak K, van der Meer J, et al. The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis. Ann Intern Med 1998;1:15-20.
25. 25. Sibai BM. Thrombophilias and adverse outcomes of pregnancy - what should a clinican do? N Engl J Med 1999;340:50-2.